Primidone
規格
125-33-7CAS番号
204-737-0EC番号
5-ethyl-5-phenyl-1,3-diazinane-4,6-dioneIUPAC名
C12H14N2O2化学式
218.25 g/mol分子量
primidone; 125-33-7; Primaclone; Mysoline; Lepimidin; 2-Deoxyphenobarbital; Lepsiral; Liskantin; Milepsin; Mylepsin; Primakton; Mysedon; Hexadiona; Prilepsin; Primoline; Prysoline; Resimatil; Majsolin; Misolyne; Mizolin; Neurosyn; Primidon; Cyral; Midone; 2-Desoxyphenobarbital; Primacone; Desoxyphenobarbitone; Pyrimidone Medi-pets; Primidona; 5-ethyl-5-phenyl-1,3-diazinane-4,6-dione; Primidonum; Roe 101; 4,6(1H,5H)-Pyrimidinedione, 5-ethyldihydro-5-phenyl-; 5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione; 5-Ethyldihydro-5-phenyl-4,6(1H,5H)-pyrimidinedione; 5-Ethyl-5-phenylhexahydropyrimidine-4,6-dione; NCI-C56360; Hexamidine (the antispasmodic); DTXSID7023510; 5-Ethylhexahydro-4,6-dioxo-5-phenylpyrimidine; 5-Ethylhexahydro-5-phenylpyrimidine-4,6-dione; 5-Aethyl-5-phenyl-hexahydropyrimidin-4,6-dion; NSC-41701; CHEBI:8412; 13AFD7670Q; DTXCID603510; Myidone; 5-24-08-00102 (Beilstein Handbook Reference); NSC41701; Apo Primidone; Mylepsin Tablets; Neurosyn Tablets; Mysoline, Apo-Primidone; RefChem:57475; Mylepsin, Primidone Medi-Pets; N03AA03; 5-Ethyl-5-phenyl-2,3-dihydropyrimidine-4,6(1H,5H)-dione; 204-737-0; Misodine; Mizodin; Sertan; Mylepsinum; Medi-Pets; 5-ethyl-5-phenyldihydropyrimidine-4,6(1H,5H)-dione; MFCD00038662; NSC 41701; Primidone(Mysoline); 5-Phenyl-5-aethylhexahydropyrimidindion-(4,6); MLS000028593; Primacione; s1965; NCGC00015834-11; CAS-125-33-7; SMR000058501; A1AIA; Primidonum [INN-Latin]; Primidona [INN-Spanish]; Primidone (primaclone); CCRIS 54; Mysoline (TN); HSDB 3169; SR-01000003162; EINECS 204-737-0; BRN 0218034; 5-ethyl-5-phenyl-1,2,3,5-tetrahydropyrimidine-4,6-dione; Hexamidine(the antispasmodic); 5-Aethyl-5-phenyl-hexahydropyrimidin-4,6-dion [German]; 5-Phenyl-5-aethylhexahydropyrimidindion-(4,6) [German]; UNII-13AFD7670Q; Primidone CRS; Primidone [USP:INN:BAN:JAN]; Primidone (Standard); Spectrum_000832; Tocris-0830; Pyrimidone 'Medi-pets'; PRIMIDONE [INN]; PRIMIDONE [JAN]; PRIMIDONE [MI]; PRIMIDONE [HSDB]; PRIMIDONE [IARC]; Opera_ID_1083; Prestwick0_000933; Prestwick1_000933; Prestwick2_000933; Prestwick3_000933; Spectrum2_001293; Spectrum3_000553; Spectrum4_000485; Spectrum5_001144; Lopac-P-7295; PRIMIDONE [VANDF]; Biomol-NT_000261; CHEMBL856; PRIMIDONE [MART.]; P 7295; Pyrimidone ''Medi-pets''; PRIMIDONE [USP-RS]; PRIMIDONE [WHO-DD]; 5-ethyl-5-phenyl-hexahydropyrimidine-4,6-dione; Lopac0_001021; SCHEMBL34221; BSPBio_000866; BSPBio_002225; KBioGR_000969; KBioSS_001312; MLS001055411; MLS001074125; BIDD:GT0319; DivK1c_000324; Primidone, analytical standard; SPECTRUM1500501; Primidone - Bio-X trade mark; SPBio_001325; SPBio_003035; Primidone (JP18/USP/INN); PRIMIDONE [GREEN BOOK]; BPBio1_000859; BPBio1_000954; GTPL5338; orb1226672; orb1311011; orb3025176; PRIMIDONE [EP IMPURITY]; PRIMIDONE [ORANGE BOOK]; PRIMIDONE [EP MONOGRAPH]; HMS501A06; HY-B0339R; KBio1_000324; KBio2_001312; KBio2_003880; KBio2_006448; KBio3_001725; WLN: T6MV DVMTJ C2 CR; PRIMIDONE [USP MONOGRAPH]; NINDS_000324; HMS1570L08; HMS1920J20; HMS2092A21; HMS2097L08; HMS2236G03; HMS3259K04; HMS3263M03; HMS3266H18; HMS3369J12; HMS3411N13; HMS3655L05; HMS3675N13; HMS3714L08; HMS3884A18; HMS5080L09; Pharmakon1600-01500501; HY-B0339; MSK10256; Tox21_110238; Tox21_201948; Tox21_303194; Tox21_501021; BDBM50248152; CCG-39231; EBC-04191; NSC757291; SBB017254; AKOS003368409; Tox21_110238_1; DB00794; FP05584; KS-5217; LP01021; NC00532; NSC-757291; SDCCGSBI-0050994.P005; IDI1_000324; SMP1_000135; NCGC00015834-01; NCGC00015834-02; NCGC00015834-03; NCGC00015834-04; NCGC00015834-05; NCGC00015834-06; NCGC00015834-07; NCGC00015834-08; NCGC00015834-09; NCGC00015834-10; NCGC00015834-12; NCGC00015834-13; NCGC00015834-14; NCGC00015834-15; NCGC00015834-16; NCGC00015834-17; NCGC00015834-19; NCGC00015834-22; NCGC00015834-26; NCGC00015834-28; NCGC00016377-01; NCGC00023254-02; NCGC00023254-04; NCGC00023254-05; NCGC00023254-06; NCGC00023254-07; NCGC00023254-08; NCGC00023254-09; NCGC00023254-10; NCGC00257146-01; NCGC00259497-01; NCGC00261706-01; BP166193; ST076725; SY052118; SBI-0050994.P004; AB00052079; EU-0101021; NS00000208; P1906; SW196576-3; 5-Ethyldihydro-5-phenyl-4,5H)-pyrimidinedione; C07371; C71997; D00474; AB00052079-14; AB00052079_15; AB00052079_16; 4,5H)-Pyrimidinedione, 5-ethyldihydro-5-phenyl-; Q420383; SR-01000003162-2; SR-01000003162-4; SR-01000003162-5; SR-01000003162-8; BRD-K32247306-001-05-4; BRD-K32247306-001-17-9; BRD-K32247306-001-27-8; BRD-K32247306-001-28-6; BRD-K32247306-001-29-4; 5-Ethyl-5-phenyldihydro-4,6(1H,5H)-pyrimidinedione #; Z1509139960; Primidone, European Pharmacopoeia (EP) Reference Standard; Primidone, United States Pharmacopeia (USP) Reference Standard; Primidone for peak identification, European Pharmacopoeia (EP) Reference Standard別名
